Atıf Formatları
A randomized trial to compare the safety and efficacy of two ranibizumab dosing regimens in a Turkish cohort of patients with choroidal neovascularization secondary to AMD
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

B. M. Eldem Et Al. , "A randomized trial to compare the safety and efficacy of two ranibizumab dosing regimens in a Turkish cohort of patients with choroidal neovascularization secondary to AMD," ACTA OPHTHALMOLOGICA , vol.93, no.6, 2015

Eldem, B. M. Et Al. 2015. A randomized trial to compare the safety and efficacy of two ranibizumab dosing regimens in a Turkish cohort of patients with choroidal neovascularization secondary to AMD. ACTA OPHTHALMOLOGICA , vol.93, no.6 .

Eldem, B. M., Muftuoglu, G., Topbas, S., Cakir, M., KADAYIFÇILAR, S., ÖZMERT, E., ... Bahcecioglu, H.(2015). A randomized trial to compare the safety and efficacy of two ranibizumab dosing regimens in a Turkish cohort of patients with choroidal neovascularization secondary to AMD. ACTA OPHTHALMOLOGICA , vol.93, no.6.

Eldem, Bora Et Al. "A randomized trial to compare the safety and efficacy of two ranibizumab dosing regimens in a Turkish cohort of patients with choroidal neovascularization secondary to AMD," ACTA OPHTHALMOLOGICA , vol.93, no.6, 2015

Eldem, Bora M. Et Al. "A randomized trial to compare the safety and efficacy of two ranibizumab dosing regimens in a Turkish cohort of patients with choroidal neovascularization secondary to AMD." ACTA OPHTHALMOLOGICA , vol.93, no.6, 2015

Eldem, B. M. Et Al. (2015) . "A randomized trial to compare the safety and efficacy of two ranibizumab dosing regimens in a Turkish cohort of patients with choroidal neovascularization secondary to AMD." ACTA OPHTHALMOLOGICA , vol.93, no.6.

@article{article, author={Bora M. Eldem Et Al. }, title={A randomized trial to compare the safety and efficacy of two ranibizumab dosing regimens in a Turkish cohort of patients with choroidal neovascularization secondary to AMD}, journal={ACTA OPHTHALMOLOGICA}, year=2015}